• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® MOLDING & OCCLUSION BALLOON CATHETER; CATHETER, INTRAVASCULAR OCCLUDING, TEMPORARY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® MOLDING & OCCLUSION BALLOON CATHETER; CATHETER, INTRAVASCULAR OCCLUDING, TEMPORARY Back to Search Results
Catalog Number MOB37
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Perforation of Vessels (2135)
Date of Event 02/16/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
H6: a review of the manufacturing records for the device verified that the lot met all pre-release specifications.H6: d1102, ifu statements: the gore® molding & occlusion balloon catheter instructions for use (ifu) was reviewed and the following ifu statements were identified in relation to the reported event.See recommended inflation volumes outlined in table 1.Do not inflate above recommended inflation volumes.Excessive inflation volume may result in balloon rupture, embolization, vessel damage, vessel rupture, or patient death.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event or Problem Description
The following information was reported to gore: on (b)(6) 2026, the patient underwent endovascular treatment for an abdominal aortic aneurysm using gore® excluder® conformable aaa endoprosthesis and gore® excluder®aaa endoprosthesis devices.Following deployment of these devices, a balloon touch-up was performed using a gore® mob balloon catheter.Subsequent angiography confirmed a distal type i endoleak originating from the right distal side.After additional balloon touch-up was performed at the site using the mob balloon, a vessel injury resembling a dissection occurred in the right common iliac artery.As a treatment, coil embolization of the right internal iliac artery was performed, followed by placement of an additional stent graft extending to the right external iliac artery to resolve the endoleak.The patient tolerated the procedure.The physician reported that excessive balloon pressure had been applied during the balloon touch-up.The anatomical configuration made it challenging to achieve a secure distal landing zone in the right common iliac artery.Therefore, aggressive ballooning in response to the distal type i endoleak should have been avoided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® MOLDING & OCCLUSION BALLOON CATHETER
Common Device Name
CATHETER, INTRAVASCULAR OCCLUDING, TEMPORARY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL PHOENIX 1 B/P
32360 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
rie kaba
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key24492828
Report Number3007284313-2026-04607
Device Sequence Number4955291
Product Code MJN
UDI-Device Identifier00733132639489
UDI-Public(01)00733132639489(17)280922
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K172567
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 03/03/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberMOB37
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/16/2026
Initial Report FDA Received Date03/03/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured09/24/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age81 YR
Patient SexMale
-
-